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AP     adapter protein, assembly protein 
ATP     adenosine 5´-triphosphate 
av-β-gal    avidin-β-galactosidase 
BB     breaking buffer 
β-gal     β-galactosidase 
bHRP    biotin-horseradish peroxidase 
bi-Tf     biotin-transferrin 
BSA     bovine serum albumin 
CCV     clathrin-coated vesicle(s) 
ci-MPR    cation-independent mannose-6-phosphate receptor 
CP     creatine phosphate 
CPK     creatine phosphokinase 
CPP     cell penetrating peptide(s) 
CPT     Center for Polymer Therapeutics 
CTR     cocktail of reagents 
DNA     deoxyribonuceic acid 
DTT     dithiothreitol 
ECV     endosomal carrier vesicle(s) 
EDTA    ethylenediaminetetraacetic acid 
EE     early endosome(s) 
EEA1    early endosome antigen 
EGF     epidermal growth factor 
EGTA                  ethylene glycol-bis(2-aminoethylether)-N,N,N´,N´-tetraacetic acid 
ELISA    enzyme-linked immunosorbent assay 
FACS    fluorescence-activated cell sorting 
FBS     foetal bovine serum  
GTPγS    guanosine-5´-(3-thiotriphosphate) 
HEPES    4-(2-hydroxyethyl)-1-piperazineethanesulfonate 
Hsp70    heat shock protein 70 
K      lysine 
LDL     low-density lipoprotein 
LE     late endosome(s) 
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LY     lysosome(s) 
MBG     methylumbelliferyl-β-D-galactopyranoside 
MU     7-hydroxy-4-methylcoumarin, methylumbelliferone 
NEM     N-ethylmaleimide 
NSF     N-ethylmaleimide-sensitive factor 
PBS     phosphate buffered saline 
PCI     photochemical internalization 
PEG     polyethylene glycol 
PI-3-kinase   phosphatidylinositol-3-kinase 
PI-3-P    phosphatidylinositol-3-phosphate 
PNS     postnuclear supernatant 
PTD     protein transduction domain 
Q      glutamine 
R      arginine 
RNA     ribonucleic acid 
RV     recycling vesicle(s) 
SDS     sodium dodecyl sulphate 
SNAP    soluble NSF attachment protein 
SNARE    soluble NSF attachment protein receptor 
Tf      transferrin 
WB     washing buffer 




There is an increasing number of macromolecular drugs (proteins, oligonucleotides 
and synthetic polymers), macromolecular conjugates and nanosized drug carriers 
(liposomes, nanoparticles) in research and development (Jones A. T. et al., 2003). Drug 
design consists of two aspects: the ability to induce desired response, which is studied 
by pharmacodynamics, and the transport of the drug to the place of action, analysed by 
pharmacokinetics. No matter how potent the drug is in vitro, it is ineffective if it can not 
reach the appropriate subcellular compartment (Kearsey J., 2004). Efficient intracellular 
drug delivery can avoid non-specific effects, reduce toxicity, allow reduction in dosage 
levels and lead to a better patient compliance. In the 1960’s polymers began to be used 
in drug-delivery systems, and scientists were forced to combine understanding of 
pharmacokinetics, biological interface and biocompati-bility (Rosen H. et al., 2005). 
Some hydrophobic molecules can pass directly through the cell membrane by a 
process of simple diffusion. Most hydrophilic substrates need a means of facilitating 
their passage into the cell, e.g. protein channels controlled by ion concentration or 
chemical messengers. Endocytosis is an energy-depennt mechanism of uptake that is 
utilised by various substances without direct passage through the cell membrane 
(Kearsey J., 2004). This pathway will be discussed in more detail later in this project.  
Particle bombardment, microinjection or electroporati n are some mechanical 
(physical) methods, that have been investigated in drug delivery to introduce 
macromolecules into cells. Viruses are used as vectors and as models for cytosolic and 
nuclear targeting. Cell penetrating peptides (CPP) containing short basic protein 
transduction domains (PTD) and their conjugates with various cargos are intensively 
studied for endosomal escape into cytosol after association with the plasma membrane 
and subsequent internalization by endocytosis. Transferrin receptor, which is over-
expressed in malignant cells, can also be exploited. ‘Smart polymers’, sometimes also 
called ‘encrypted polymers’, are promising drug carriers into cytosol. Bio-inspired, pH-
responsive polymeric carriers can disrupt endosomal embrane in a pH-dependent 
fashion (Murthy N. et al., 2003). On the endocytic pathway there is a decrease in pH 
from pH 7.4 to approximately pH 4.5. This pH drop serves as  a trigger for a 
conformational change of  the polymer leading to its conversion from a hydrophilic coil 
to a hydrophobic helix, which is membrane active and therefore can disrupt the 
endosomal border. Another way is masking of disruptive part of molecule by 
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polyethylene glycol (PEG) chains conjugated via acid-labile acetal linkage and the low 
pH in the endosome will then allow release of the trapeutic cargo (Hoffman S. A. et
al., 2003). The final therapeutic agent contains pH-sensitive polymer (or masked 
membrane-disruptive polymer), targeting ligand for receptor-mediated endocytosis and 
the drug. 
Another approach uses the features of light. Photocemical internalization (PCI) 
can improve cytosolic delivery of endocytosed drugs. Photosensitizing compounds, 
such as aluminium phthalocyanine, localized in endocytic vesicles induce 
photochemical damage of the vesicular membranes upon light exposure and therefore 
intact macromolecules can be released into the cytosol. Only areas exposed to light are 
subjected to the drug effect. It is interesting that e illumination can be performed even 
before the drug uptake. This pre-permeabilisation of endocytic vesicles is suitable 
especially for the light-unstable drugs (Prasmickaite L. et al., 2002). 
Liposomes are able to provide protection and targetin  of the encapsulated 
macromolecule (Fretz M. M. et al., 2005). The disadvantage of such a lipid-based 
compound is a rapid removal from blood circulation by the reticuloendothelial system. 
The science and medicine can not rely only on small compounds and therefore 
need to find the ways how to make large molecules efficient in therapy. Drug-delivery 
technologies come into play earlier in the development cycle, they can even rescue 
failed compounds, such as those with low solubility (Rosen H. et al., 2005). Diseases 
associated with intracellular compartments, strategies for delivering drugs into those 
compartments and crossing the numerous biological barriers lying between drug 
administration and effect are on the top list of today’s research (Jones A. T., 2001). 
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It is estimated that more than 10% of human genome is implicated in controlling 
membrane trafficking pathways. Macromolecular drugs are candidates for cellular 
uptake by the mechanism of endocytosis (Jones A. T. et al., 2003). Endocytosis is a 
fundamental process performed by all eukaryotic cells. It is characterised by the 
continuous and regulated formation of prolific numbers of membrane vesicles at the 
plasma membrane (Mellman I., 1996). The basic mechanism is the reverse of what 
occurs during exocytosis or cellular secretion. Endocytosis is essential for cell 
homeostasis and plays a key role in membrane dynamics and response to extracellular 
stimuli by recycling, down-regulating and desensitizing of receptors and membrane 
proteins (D’Hondt K. et al., 2000). Cells use endocytosis for a number of cellular 
processes including uptake of nutrients, for transmis ion of metabolic, neuronal and 
proliferative signals, for defence against microorganisms. Many infectious agents hijack 
this pathway as their entry route to the host cell (Mellman I., 1996). 
The process involves invagination, or folding inward of the plasma membrane, 
surrounding the external space, pinching off (budding) and releasing the vesicle to the 
cytoplasm. The vesicles deliver their content into a number of intracellular organelles 
including lysosomes for degradation (lysosomotropic delivery, 30 - 60 min). Membrane 
components of endocytic vesicles are subject to highly complex and iterative molecular 
sorting events resulting in their targeting to specific destinations such as Golgi network 
or relatively rapid recycling out of the cell (5 - 10 min) or at the opposite part of plasma 
membrane in the case of transcytosis. The entire cell surface is internalized at least once 
or twice per hour (Mellman I., 1996, Jones A. T. et al., 2003). 
There are two general types of endocytosis: phagocytosis, where large particles    
(≥ 500 nm) are internalized into phagosomes, and pinocytosis, the uptake of particles 
(usually ≤ 200 nm) dissolved in a fluid phase or receptor-mediat  internalization into 
endosomes.   
 
Phagocytosis 
Phagocytosis is generally restricted to motile cells. Some species of protozoa use 
phagocytosis for a nutritional reasons and distinct cell types of mammalian immune 
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system (neutrophiles and macrophages) use pseudopodia extensions for a defence 
against invading pathogens or for collecting defectiv  or old cells. This receptor- 
mediated process is often facilitated by opsonins, that bind to a foreign particle and 
make it distinguishable for the receptors of motile blood cells. When the phagosome is 
formed, it matures by a series of vesicle fusion and fission reactions and finally 
combines with lysosome to create a phagolysosome, in wh ch the ingested particles are 
degraded (Pollard T. D. et al., 2002). Phagocytosis is a very complex process involving 
specialized plasma membrane receptors, rearrangement of cytoskeletal elements and 
dynamic exchange of phagosomal components with several intracellular compartments 
(Berón W. et al., 1995). 
 
Pinocytosis 
Pinocytosis can be generally split into clathrin-dependent and clathrin-independent 
endocytosis. At least four distinct processes have been suggested to provide endocytic 
activity in the absence of clathrin, these are caveolae mediated uptake, adsorbtive 
endocytosis, fluid-phase uptake and macropinocytosis. 
Caveolae (~ 60 nm) are flask-shaped plasma membrane invaginations, 
characterised by a coat consisting of caveolins. These are able to internalize e.g. cholera 
toxin or ricin (Mineo Ch. et al., 2001). Caveolin-1 in non-muscle cells and caveolin-3 in 
muscle cells are integral membrane proteins, that serve as markers of caveolae. 
Caveolae have been considered to be a specialised form of lipid raft domains with a 
unique morphology generated by caveolin. Lipid rafts are highly ordered lipid 
microdomains in exoplasmatic leaflet of the plasma membrane caused by the interaction 
of sterols (cholesterol, ergosterol) and sphingolipids. Lipid rafts may selectively 
incorporate proteins, therefore act as dynamic organizers of protein interactions during 
membrane transport or signal transduction (Ikonen E., 2001). Caveolae endocytosis 
appears to be a constitutive dynamin-dependent process formed by the interaction 
between caveolin and cholesterol (Ikonen E. et al., 2005).  
Adsorbtive endocytosis is an uptake process based on the interactions between 
positively charged particles and the negatively charged plasma membrane.  
Cells continuously internalize fluid from their surroundings to ensure the sampling 
of the environment. Fluid-phase endocytosis could be a type of surveillance in 
mammalian cells. Alternatively it could be a mechanism of washing the bulk of plasma 
membrane by passing through acidic endosomes to remve nonspecifically adsorbed 
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molecules. In lower organisms it plays an essential role in nutrient uptake (Pollard T. D. 
et al., 2002). 
Macropinocytosis is a term used to describe the intrnalization of large areas of 
plasma membrane together with significant amounts of fluid. Large irregular 
macropinosomes (sometimes greater than 1 µm) are formed during extensive actin 
rearrangement. Finding that this process is inhibited by cholesterol depletion suggests 
that macropinocytosis is another lipid raft-dependent pathway. 
Clathrin-dependent endocytosis provides the uptake of receptor-bound ligand 
complexes and extracellular fluid. Receptor-mediate means taking up specific ligands 
that bind to complementary cell-surface receptors. The process is typically initiated by 
formation of clathrin-coated vesicles (CCV) at the plasma membrane (Fig. 1). After 
losing the coat by the process of depolymerisation, hese vesicles (~ 120 nm) are able to 
fuse with early endosomes (EE). EE form a tubulovesicular compartment in peripheral 
cytoplasm and are crucial for sorting events. Due to an ATP-dependent proton pump the 
pH gradually decreases through the endocytic pathway. Slightly acidic pH of EE causes 
dissociation of receptor-ligand complexes (Mellman I., 1996). Receptors accumulate in 
tubular part of EE and can be returned to the plasma membrane in recycling vesicles 
(RV). Ligands and other soluble molecules are stored in vesicular part of EE and after 
fission of tubular extensions are moved as endosomal carrier vesicles (ECV) to late 
endosomes (LE). Degradative enzymes are active in this compartment, but are more 
concentrated in lysosomes. Lysosomes are the final compartment of the endocytic 
pathway and can be distinguished from LE by higher density (Clague J. M., 1998). An 
ability to inhibit or alter traffic to later endocytic compartments has distinct advantages 
for drug-delivery strategies (Jones A. T. , 2001). 
 
 
Figure 1. Clathrin-dependent 
endocytosis. CCV – clathrin 
coated vesicle, EE – early 
endosome, ECV – endosomal 
carrier vesicle, RV – 
recycling vesicle, LE – late 
endosome, LY – lysosome. 
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Recycling of transferrin 
A well-described example of receptor-mediated endocytosis is the internalization 
and recycling of transferrin. Transferrin (Tf) is a major mammalian serum glycoprotein 
and transports iron from sites of absorbtion and storage to tissue cells. Receptors for Tf 
are found on all growing cells (Dautry-Varsat A. et al., 1983). Transferrin receptors 
have long been explored as a target for receptor-mediated delivery of anticancer drugs 
and genes and also as a means of transfer drugs across epithelial barriers via transcytotic 
pathways. Not-surprisingly these are upregulated in rapidly dividing cells as cancer 
cells usually are (Jones A. T. et al., 2003). Diferric transferrin (also called 
ferrotransferrin) binds to cell surface receptors and the complex is internalized 
(endocytosed). The pH of the early endocytic vesicl (5.9 – 6.0) causes dissociation of 
iron from the transferrin-receptor complex. The iron remains in the cell and is released 
from EE to the cytosol. Iron-free transferrin called apotransferrin remains bound to its 
membrane receptor and is recycled within RV to the cell surface. At the neutral pH of 
extracellular fluid apotransferrin dissociates from the receptor and is then available for 
binding other two iron atoms. This cycling is caused by binding activity of Tf and its 
iron-free analogue. At pH 5.9 apotransferrin binds to membrane transferrin receptors to 
the same extent and with the same affinity as does diferric transferrin at pH 7.0. 
Apotransferrin is quickly dissociated from this receptor when the pH is raised to 7.0 
(Dautry-Varsat A. et al., 1983). 
 
Rab proteins 
There are various characteristic proteins (biochemical markers) for distinct 
endocytic compartments. Rab proteins are small GTPases belonging to ras superfamily, 
that regulates vesicular transport during endocytosis. They have been implicated 
principally in the control of vesicle docking and fusion. Rab activity is partly controlled 








Compartment pH Marker proteins 
Early (sorting) endosomes - EE 5.9 – 6.0 rab4, rab5, transferrin receptor, EEA1 
Recycling vesicles - RV 6.4 – 6.5 rab4, rab11, transferrin receptor 
Endosomal carrier vesicles - ECV < 6  
Late endosomes - LE 5.6 - 6.0 rab7, rab9, ci-MPR, lgps, lamps 
Lysosomes - LY 5.0 – 5.5 lgps, lamps 
 
Table 1. Characteristics of organelles on the endocytic pathw y (Reproduced from 
Clague J. M., 1998). Cation-independent mannose-6-phosphate receptor (ci-MPR), 
highly glycosylated and conserved members of protein family enriched in late 
endosomal and mainly lysosomal compartment (lgps, lamps). 
 
2.2. Clathrin-dependent endocytosis 
 
Internalization 
Receptors determined for this type of endocytosis selectively accumulate at plasma 
membrane coated pits. Most of them are transmembrane proteins and they need sorting 
signals to be internalized (D’Hondt K., 2000). So-called internalization motifs encoded 
in cytoplasmic domains of these receptors are crucial for a coat assembly (Pollard D. T. 
et al, 2002). The best characterised is a YXXØ motif, where Y is tyrosine, X represents 
any aminoacid and Ø represents a bulky hydrophobic amino acid. Alternatively 
dileucine, dilysine motif, acidic cluster of amino acids or ubiquitination can serve as an 
internalization signal. Receptors can be endocytosed constitutively (LDL or transferrin 
receptor) or only after ligand binding and conformational change of cytosolic domain 
such as in the case of EGF (epidermal growth factor) receptor (Clague J. M., 1998). 
Transmembrane proteins lacking internalization signals are not internalized in these pits 
(Lodish H. et al., 2000). The pits must function as molecular filters collecting certain 
plasma membrane proteins (receptors) and excluding others. Many kinds of receptors 
cluster in the same coated pit (Alberts B. et al., 1994). 
The targeting and transport specificity of the clathrin coat is derived from adapter 
or assembly protein (AP) components of the coat. The plasma membrane AP-2 complex 
consists of two large chains (α2 and β2 adaptins), an intermediate µ2 chain and a small 
chain σ2. The intermediate chain binds to a cytoplasmic domain of transmembrane 
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receptor and both large chains contain clathrin binding sites. Moreover there are other 
additional proteins linking AP complex to plasma membrane. Synaptojanin, 
amphyphisin and dynamin are the most famous ones. Amphyphisin binds to AP and 
recruits dynamin to the neck of budding vesicles. Synaptojanin binds to amphyphisin 
and also to dynamin (Lodish H. et al., 2000). The APs are proposed to link cargo 
selection to a clathrin coat (D’Hondt e al., 2000). On the whole, major components of 
the endocytic clathrin coated vesicle are AP-2 complex, clathrin triskelions and 
dynamin. Another class of proteins that may function n a manner similar to AP 
complexes are arrestins. 
Purified clathrin molecules are called triskelions and contain three heavy chains 
and three light chains. After binding to AP-2 complex clathrin molecules polymerize 
and form polygonal lattice with an intrinsic curvature shaped as a cage (Lodish H. et al., 
2000). An essential protein required for budding of CCV is dynamin. Dynamin is a 
large GTPase which works as a mechanochemical enzyme (D’Hondt et al., 2000). After 
dynamin subunits polymerize around the neck of a pit and form a collar (a ring-like 
structure), hydrolysis of GTP is thought to regulate contraction of the polymeric 
dynamin until the vesicle pinches off (Lodish H. et al., 2000). 
 
CCV’s 
Even though CCV’s are stable in the microenvironment of cytosol they lose their 
coat and the assembly particles just after their formation. A cytosolic chaperon protein 
Hsp70 catalyzes depolymerization of clathrin into triskelions, which can be reused 
(Lodish H. et al., 2000). Uncoated vesicles are able to fuse with early endosomes. The 
fusion conditions are assumed to be similar to EE homotypic fusion discussed later. 
 
Early endosomes 
Although the selective inclusion of receptors at plsma membrane coated pits is the 
initial sorting event during endocytosis, early endosomal compartment serves as a more 
specific level of sorting and quality control (Jones A. T. et al., 2003). Many proteins 
and lipid microdomains establishing the destination of endocytosed material have been 
already described. EE form dynamic tubulovesicular structures that interchange 
components with other endosomes, the Golgi complex and the plasma membrane 
through budding and fusion events (Berón W. et al., 1995). The endosomal lumen is 
acidified through the activity of a proton pump, the vacuolar ATPase (Pollard D. T. et 
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al., 2002). Therefore EE host the initial dissociation f receptor-ligand complexes. 
Receptors and other membrane proteins accumulate in the tubular extensions and 
soluble contents accumulate in vesicular regions. The tubular parts pinch off to form 
recycling vesicles and the vesicular elements proceed to LE and lysosomes (Mellman I., 
1996). Transit through EE is very rapid (2 - 3 min). 
 
Early endosome fusion 
The most widely studied fusion event on endocytic pathway of mammalian cells is 
homotypic fusion between early endosomes. In vitro assays that reconstitute this event 
have been constructed (Clague J. M., 1998) and will be discussed later. 
Homotypic fusion is a fusion between vesicles that can not be distinguished using 
cell markers such as those described in Table 1. The reason for this fusion rises from the 
need of membrane for recycling tubular elements of EE. Because a sphere has the 
smallest ratio of surface area to volume, when two vesicles of equal diameter fuse with 
each other to form a larger sphere containing twice the volume, excess membrane is 
generated. Multiple fusion events generate large amounts of excess membrane. The 
excess membrane can be removed in a form of tubules, which have a high surface-to-
volume ratio (Pollard D. T. et al., 2002). 
There are thousands of shuttle vesicles in the cytosol at any one time and their task 
is to specifically find their target organelle, dock with it and deliver their cargo by 
fusing with the target membrane. This is aided by a number of cytosolic proteins that 
bind to membranes to mediate a traffic effect. Early endosome antigen (EEA1) is an 
example of one of these proteins and was discovered as an autoantigen associated with 
subacute cutaneous systematic lupus erythematodus. This protein resides in cytosol and 
specifically associates with the cytoplasmic face of the EE membrane. It has not been 
detected on other membrane compartments. EEA1 contains a double zinc finger on C-
terminus, that is a cysteine rich domain also called FYVE domain. This part of EEA1 
molecule interacts with phosphatidylinositol-3-phosphate (PI-3-P) and is a 
determination for endosomal targeting. PI-3-P is created from phosphatidylinositol in 
energy dependent process catalysed by phosphatidylinositol-3-kinase (PI-3-kinase). 
Other two binding sites in EEA1 molecule were found to be effectors of active form of 
rab5 (GTP form). The interaction between EEA1 of one endosome and rab5 of the 
second one acts as a docking/tethering signal necessary before EE fusion event (Wilson 
M. J. et al., 2000). A fungal metabolite wortmannin, a specific inhibitor of PI-3-kinase, 
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has multiple effects on endocytic processes including inhibition of fluid-phase uptake 
and early endosome fusion. Wortmannin causes dissociation of EEA1 from endosomal 
membrane and therefore inhibits fusion of EE (Jones A. T. et al., 1995). A protein 
called rabex 5, that associates with rabaptin 5, catalyzes the exchange of GDP bound to 
cytosolic rab5 for GTP inducing a conformational change in rab5, allowing it to bind to 
a surface protein on a particular endosome (Lodish H. et al., 2000). 
After the docking of vesicles, fusion can proceed. Each vesicle has a pair of 
SNAREs (soluble NSF attachment protein receptors). Every v-SNARE (originally for 
donor vesicle) specifically binds to a cognate t-SNARE (a target membrane in the case 
of heterotypic fusion). SNAREs fit together like a key and a lock. N-ethylmaleimide-
sensitive factor (NSF, NEM sensitive factor) and SNAP (soluble NSF attachment 
protein) bind to the t-SNARE/v-SNARE complex to stabilize perfusion complex. 
Fusion of the two membranes immediately follows prefusion. Finally the t-SNARE/v-
SNARE complex must dissociate, probably in the presence of NSF and SNAP (Lodish 
H. et al., 2000). After untangling of SNAREs the new vesicle is capable of another 
fusion or step. 
 
Late endosomes and lysosomes 
After the detachment of recycling tubules, the vacuolar portions of EE move as 
endosomal carrier vesicles (ECV), sometimes also called multivesicular bodies, along 
microtubules toward the perinuclear region. Here th vesicles can fuse with LE, or 
according to another theory they maturate by processes of recycling and gradual gaining 
lysosomal hydrolases (Pollard D. T. et al., 2002). LE contain constituents of the fluid 
phase with very few receptors. LE also communicate ext nsively with Golgi network. 
LE are enriched in lgps/lamps, rab7, rab9 and ci-MPR. There is an active exchange of 
material between LE and lysosomes, where hydrolytically active enzymes initiate the 
degradative process.  Lysosomes are distinguished from LE by higher density and the 
absence of ci-MPR, rab7 and rab9 (Mellman I., 1996). 
 
2.3. In vitro assays of vesicular transport 
 
The understanding of the molecular mechanism governing movement of proteins 
and lipids between the various compartments of eukaryotic cells is a key goal of cell 
biological research. This aim has been greatly facilit ted by the development of assays 
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that reconstitute specific traffic events in vitro. The primary requirement for such 
experiments is a method for preparing membranes containi g suitable markers. Mainly 
fusion events in various stages of endocytic pathway are studied. Assays of trafficking 
within the endocytic pathway have mainly focused on mixing of two complementary 
probes separately introduced into the donor and acceptor organelles. It is essential to 
ensure that the reaction occurs in sealed organelles and is prevented if either 
compartment is leaky (Cook R. N. et al., 2001). 
All the assays can be subdivided into two groups according to the way of 
preparation of membranes. Cell free assays, using postnuclear supernatants (PNS) or 
purified subcellular fractions, and broken cell assays, in which the plasma membrane is 
disrupted by mechanical or chemical means, but the organisation of the internal 
organelles remains largely intact. The single most crucial parameter is to find optimal 
conditions for cell breakage (Cook R. N. et al., 2001). 
 
Cell free assays 
All the homotypic and most of heterotypic fusion ass ys use cell free systems. The 
major advantage is that individual membrane preparations can be stored as frozen 
aliquots. Moreover the absence of nucleus permits more extreme treatments. 
Conversely, the major disadvantage is the reduced ov rall efficiency of the reaction. 
The techniques of homogenisation comprise a ball homogeniser (cell cracker), a 
passage through a narrow gauge needle, freezing-thawing with violent mixing and 
sonication (Cook R. N. et al., 2001). 
 
Broken cell assays 
The primary advantage of this methods is the increased efficiency of the assay 
(may exceed 80%). The disadvantage is the need to prepare fresh membranes on each 
occasion. Broken cells can be prepared from adherent cells by selective disruption of 
the mammalian plasma membrane. Mechanical shear of adherent cells or scraping with 
a ‘rubber policeman’ can be used. Large holes are created allowing release and capture 
of transport vesicles, although the subcellular archite ture is largely maintained. 
Selective disruption of the plasma membrane in suspen ed cells can be achieved by 
gentle homogenisation in ball homogeniser or by freezing-thawing. Both types of cells 
(adherent and suspensed) can be permeabilised by treatment with mild detergents such 




The most widely used endocytic assay systems are bas d on mixing of an avidin-
enzyme conjugate with a biotinylated probe (Cook R. N. et al., 2001). There is an 
exceptionally high affinity constant and low dissociation constant of the egg-white 
glycoprotein avidin (or its bacterial counterpart st eptavidin) and the vitamin biotin. The 
general idea of this approach is that biotin, coupled to low- or high-molecular-weight 
molecules, can still be recognized by avidin, either as the native protein or bound to e.g. 
enzyme or fluorescent group. Avidin-biotin system serves as a universal tool in the 
research. The major applications are in immunoassays, affinity chromatography, flow 
cytometry or fluorescent microscopy. The disadvantage, which has to be solved, is the 
presence of certain ‘undesirable’ structural properties in the avidin molecule, which 
may lead to high levels of ‘non-specific’ binding (Bayer  A. E. et al., 1990). 
 
Performance of in vitro fusion assays 
Gruenberg and Gorvel used an in vitro assay for reconstitution of early endosome 
fusion. Avidin and biotinylated horseradish peroxidase (bHRP) were chosen as markers. 
After the internalization step, when the markers were separately introduced into EE, the 
cells were homogenised and fractions containing EE were combined in the presence of 
ATP and cytosol. Following fusion a complex between avidin and bHRP was formed. 
Finally the membranes were broken by detergents in the presence of a quenching agent, 
biotinylated insulin, that binds free avidin. The avidin-bHRP was then 
immunoprecipitated with anti-avidin antibody and the enzymatic activity of bHRP was 
measured. The substrates of HRP  (o-dianisidine and H2O2) were used and the brown-
coloured product was quantified in a spectrophotomeer at 455 nm (Graham J. M. et al., 
1997). 
Another assay was performed by Davey, Hurtley and Warren. The reaction 
between enzyme and substrate endocytosed separately into EE was used. Both the 
enzyme and the substrate were provided by enveloped animal viruses that use endocytic 
pathway as a means of entering cells during infection. Fowl plague virus with its own 
enzyme neuraminidase and Semliki Forest virus possesing tritium-labeled sialic acid 
residues were endocytosed. PNSs were prepared. The cells were first broken 
(homogenised) by several passages through homogeniser and the homogenate was 
centrifuged. The supernatant was stored at -80°C and after thawing, it was used for 
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fusion. The fusion enabled the neuraminidase of Fowl plague virus to cleave the tritium-
labeled sialic acid residues. The fusion was monitored by determination of the amount 
of  tritium-labeled sialic acid (Davey J. et al., 1985). 
Woodman and Warren studied fusion between endocytic vesicles containing 125I-
transferrin and ones containing anti-transferrin antibody. The immune complex was 
quantified (Woodman G. P. et al., 1988). 
All the assays use high potassium isoosmotic solutions buffered to approximate 
neutrality and contain an ATP regenerating system (creatine phosphate and creatine 
phosphokinase). Typically the mixtures of HEPES, KCl and sucrose are used (Cook R. 
N. et al., 2001). 
 
Outcomes of in vitro assays 
The major application of in vitro assays is the identification of the factors that are 
required for the reconstitued event. They can be also used to investigate the effects of 
drugs/macromolecules on the events studied. Now it is possible to reconstitue some 
steps using purified proteins instead of cytosol (Cook R. N. et al., 2001).  
EE fusion is a time, temperature, cytosol and energy dependent event. NEM 
inhibits this effect and this led to the discovery of NSF as a fusogenic factor. It was 
elucidated that fusion was not dependent on the acidic microenvironment of EE, 
because NH4Cl did not inhibit the assay (Wessling-Resnick M. et al., January 1990). 
When the fusion assay was carried out in the presenc  of mitotic cytosol, the fusion 
activity was reduced. This finding indicated that EE fusion was arrested during mitosis 
because of the cell-cycle control protein kinase cdc2 (Tuomikoski T. et al., 1989). The 
nonhydrolyzable nucleotide analog guanosine-5´-(3-thiotriphosphate) GTPγS was found 
to inhibit fusion and does this before the NEM sensitive step. The factor inhibited by 
GTPγS was identified as a rab5. Other functions of rab5 were later discovered. The 
addition of the fungal metabolite wortmannin, known to be a specific inhibitor of PI-3-
kinase, was found to inhibit EE fusion (Jones A. T. et al., 1995). The comparison of 
yeast and mammalian cells led to the finding that some of the proteins governing the 
traffic events are highly conserved. This is demonstrated by the fact that fusion between 
vesicles originating from different cell types can occur. PNS prepared from K562 cells 
(human leukaemia cell line) containing avidin-linked probe can be employed in cell free 
fusion assays in conjunction with PNS with biotinylated probe originated either from 
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chinese hamster ovary cells or from K562 cells (Wessling-Resnick M. et al., October 
1990). This was the assay studied in this project at Cardiff university. 
 
2.4. Development of in vitro assays of early endosome fusion 
 
The method used was developed by Marianne Wessling-Resnick and William 
Braell in 1990 (Wessling-Resnick M. et al., January 1990). A cell free system in this 
work utilizes a fluid phase probe (avidin coupled to β-galactosidase (av-β gal)) and a 
modified ligand of the transferrin receptor (biotin- ransferrin (bi-Tf)). K562, a highly 
undifferentiated cell line of the granulocytic series, is used for cell extracts preparation. 
The fusion of EE was monitored through the associati n reaction between the 
internalized avidin- and biotin-linked probes. The complex of β-gal-av-bi-Tf is formed 
after a successful fusion event. When the vesicles ar  lysed, the complex is released and 
can be captured in the wells coated with anti-transferrin antibody. The fusion can be 
quantified through β-gal, which converts the non-fluorescent substrate 
(methylumbelliferyl-β-D-galactopyranoside, MBG) to a fluorescent product 
(methylumbelliferone, MU). 
  
Internalization and cell extracts preparation 
K562 cells need to be harvested, washed with phosphate buffered saline (PBS) and 
resuspended in uptake buffer containing either av-β-gal or bi-Tf as EE probes. The 
probes can then be internalized under specific conditi s. All the steps following 
internalization must be performed on ice. For PNS preparation the cells are resuspended 
in breaking buffer (BB) and the sample is passed several times through stainless steel 
ball homogenizer up to 90% cell breakage. PNS (containi g EE and other membranes) 
are finally separated from heavier nuclei and intact cells. After protein concentration 
determination are the aliquots stored at -80°C.  
 
In vitro vesicles fusion 
PNS preparations containing internalized av-β-gal and bi-Tf  are mixed on ice in a 
mixture including 1 mM ATP, 50 µg/ml creatine phosphokinase (CPK), 8 mM creatine 
phosphate (CP), 10 µg/ml biotin-insulin and 1 mM dithiothreitol (DTT). The final 
recommended protein concentration is 2 – 4 mg/ml. The addition of biotin-insulin into 
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the mixture serves as a scavenger of any avidin-linked probe, which may be present due 
to lysed vesicles. After the incubation of the reaction mixture at 37°C for 30 min the EE 
fusion is quenched by addition of membrane-disrupting lysis buffer. 
 
ELISA procedure (MBG assay) 
The fusion between EE is monitored by enzyme-linked immunosorbent assay 
(ELISA) procedure. Rabbit anti-transferrin antibody in a coupling buffer is incubated in 
wells at 4°C overnight (alternatively at 37°C for 3 hours). Coated wells are washed and 
filled with lysed sample. The samples are incubated for three hours and after washing 
the wells the β-gal activity as ‘anti-Tf antibody – Tf-bi – av-β-gal’ is measured. A 




Figure 2. In vitro assay of early endosome fusion. 
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2.5. Cell penetrating peptides 
 
Plasma membrane effectively prevents the uptake of macromolecules by limiting 
their passive entry. Traditional approaches to modulate protein function have relied on 
the discovery of specific drugs and small molecules, which could be easily delivered 
into the cell. However unlike ‘information-rich’ macromolecules, they often suffer from 
poor target specificity, unwanted side-effects and toxicity.  
Remarkably the identification of a particular group of proteins with enhanced 
ability to cross the plasma membrane in a receptor-independent fashion has led to the 
discovery of a class of protein domains with cell membrane penetrating properties 
(Wadia S. J. et al., 2005). Not only do these proteins pass through the plasma 
membrane, but they are also able to act as vectors for small molecule drugs 
(doxorubicin), DNA (tumor suppressor gene p53), antise se oligonucleotides, peptides, 
proteins (β-galactosidase, horseradish peroxidase, RNAase A, Cre recombinase, green 
fluorescent protein), liposomes and even inorganic 40 nm iron particles (Wadia S. J. et 
al., 2005). 
 
Protein transduction domains 
 The best characterised peptides are those derived from HIV-1 transcriptional 
activator Tat protein, herpes simplex virus structural protein VP22 and Drosophilla 
melanogaster homeoprotein antennapedia transcription protein. The study of HIV has 
provided striking insights into the molecular biology of eukaryotic cells including 
macromolecular transport into and out of the nucleus, intracellular trafficking of 
proteins or fusion of lipid bilayers (Greene C. W. et al., 2002). HIV-1 Tat protein plays 
a critical role in viral replication. It is organised into three functional domains, one of 
them, called basic region, is thought to be required for nuclear import (Wadia S. J. et
al., 2005). This sequence has been intensively studied and shorter domains have been 
characterized. The part extending from residues 49 to 57 (RKKRRQRRR) is generally 
considered to be the minimal sequence responsible for the cell internalization (Caron J. 
N. et al., 2004). Because arginine is a main component of this domain, synthetic 
peptides were prepared and tested both in vitro and in vivo. Octaarginine (R8) showed 
internalization characteristics similar to those of the Tat peptide (Nakase I. et al., 2004). 
There is no homology between the primary and secondary structure of these PTD and 
the rate of cellular uptake has been found to correlate to the number of basic arginine 
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residues present (Wadia S. J. et al., 2004). Even peptides synthesized from either D- or 
L-amino acids and reversed amino acid sequences are inte nalized (Lundberg M. et al., 
2003). 
 
Mechanism of internalization 
Cellular mechanisms of Tat peptide uptake and internalization are still largely 
unexplored. The binding of Tat peptide to the plasm embrane does not involve any 
specific receptors, is not affected by low temperature and is saturable at very high 
protein concentration. The basic character of PTDs indicates the dependence on non-
specific interactions between the charged side groups of arginine residues (guanidine 
head group is a critical structural feature) and sulfated-membrane-bound glycoproteins 
such as heparan sulfate proteoglycans (Tyagi M. et al., 2001). Each arginine is highly 
charged at physiological pH and can donate a hydrogen allowing the formation of stable 
hydrogen bonds with anions such as sulfate (Wadia S. J. et al., 2005). It has been 
estimated that internalization occurs by a constitutive lipid- and temperature-dependent 
macropinocytosis and that binding of the Tat PTD to the cell surface is sufficient to 
stimulate macropinocytotic uptake (Wadia S. J. et al., 2005). Possibly more than one 
pathway is involved in internalization. Although macropinosomes are thought to be 
inherently leaky vesicles compared to other types of endosomes, the majority of the Tat 
proteins remains trapped within these compartments where they are non-functional. Tat 
protein transduction domain does not appear to involve any distuption of the plasma 
membrane (Wadia S. J. et al., 2005). It has been shown that endosome disruption w th 
choroquine can significantly increase Tat-fusion protein access to the cytosol and 
nucleus (Caron J. N. et al., 2004). The positive charge of PTDs allows these proteins in 
case of escape from endosomes to bind to negatively charged structures within the cells, 
such as DNA (Lundberg M. et al., 2003).  
 
Discrepancies in findings 
Many different results have been published regarding PTDs, however some 
artifacts concerning the cellular localization of various entities have been reported. A 
cellular redistribution with nuclear targeting of these proteins following cell fixation 
was demonstrated (methanol, ethanol, acetone and paraformaldehyde cause membrane 
disruption). FACS (flow cytometry analysis) quantification appeared to have been 
overestimated by extensive signal from the non-internalized peptide, which adheres 
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very strongly to the cell surface. Trypsin treatment has to be used prior to FACS 
analysis. Nevertherles there are over 50 demonstrations of biological responses obtained 
with cargos vectorized by various PTDs (Vives E., 2003). There are several 
explanations for this phenomenon: (1) PTD proteins exert effects on the cell surface, 
probably by affecting the receptors of plasma membrane, (2) the proteins exert their 
effect within endosomes, where the effect does not depend on cytosolic or nuclear 
localisation (β-gal, magnetic nanoparticles), or (3) the PTDs are rel ased from the 
endosomes into the cytosol by endosomolysis. It is likely that endosomolysis is an 
infrequent event and only a few of the endosomes rel as  their contents into the cytosol. 
It is very difficult to make any conclusion regarding PTDs because of wide variety 
of the PTDs sequences used as cell penetrating peptides, large differences within the 
cargos (size, composition, physicochemical properties), different types and lengths of 
linkage between peptide and cargo, variable concentration of PTDs fusion chimeras, 
large heterogenity of cell types and protocols used in experiments (Brooks H. et al., 
2005). 
 
Factors which affect a particular proteins function by mutation, deletions in the 
amino acid sequence, changes in expression (overexpr ssion, suppression) lead to 
alterations in normal cellular function and often uderlie a wide variety of genetic and 
acquired disorders. The ability to manipulate cell biology at the protein level would 
provide us with a powerful tool for treatment of variety human diseases including 
cancer (Wadia S. J. et al., 2004). 
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3. AIMS OF THE PROJECT 
 
The main goal of this project was to set up an in vitro assay of early endosome 
fusion. Antibodies against cytosolic proteins required for fusion and fusion inhibitors 
such as wortmannin, NEM and local anaesthetic could then have been studied to verify 
that the assay conforms with published literature. To date there are no studies on the 
effects of CPP on early endosome fusion and this could be easily tested provided an in-
house assay was available. This knowledge would have gi en important information 
regarding the peptides putative effects on the integrity of the endosomal system. 
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Phosphate buffered saline tablets (PBS), potassium chloride (KCl), magnesium 
chloride (MgCl2), sodium hydroxide (NaOH), L,D-dithiothreitol (DTT), 
ethylenediaminetetraacetic acid (EDTA), ethylene glycol-bis(2-aminoethylether)-
N,N,N´,Ń-tetraacetic acid (EGTA), trometamol (Tris, TRIZMA base), octylphenol 
ethylene oxide condensate (Triton X-100), sodium 4-(2-hydroxyethyl)-1-
piperazineethanesulfonate (HEPES sodium salt), bovine serum albumin (BSA), 
heparine sodium salt from porcine intestinal mucosa, 4-methylumbelliferyl-β-D-
galactopyranoside (MBG) and adenosine 5´-triphosphate disodium salt (ATP) were 
purchased from Sigma (Dorset, UK). Glucose, sucrose, ethanol, sodium chloride 
(NaCl), sodium carbonate (Na2CO3) and hydrochloric acid (HCl) were purchased from 
Fisher Scientific Laboratories (Leicestershire, UK), creatine phosphate disodium salt 
(CP) and creatine phosphokinase (CPK) from porcine heart were purchased from 
Calbiochem (Nottingham, UK) 
 
Protein conjugates 
Insulin-biotin labelled from bovine pancreas, β-galactosidase (lactase, β-gal) and 
avidin-β-galactosidase (av-β gal) were purchased from Sigma (Dorset, UK), biotin-
transferrin (bi-Tf) was purchased from Molecular Probes (Leiden, Netherlands) and 
rabbit anti-human transferrin (anti-transferrin antibody) was purchased from Research 
Diagnostics, Inc.(Concord MA, USA). 
 
Cell culture 
K562 cells were purchased from ECACC (Wiltshire, UK), RPMI 1640 media 
containing L-glutamine, foetal bovine serum (FBS) and trypan blue solution 0.4% were 
purchased from Gibco BRL (Paisley, UK). 
 
Buffers and solutions  
Buffer A – 150 mM NaCl, 25 mM HEPES, pH 7.4 
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Bradford dye stock – 100 mg of Coomassie Brilliant Blue G-250, 50 ml of 95% ethanol, 
100 ml of 85% H3PO4 made up to 1 liter with distilled water. 
Breaking buffer (BB) - 0.1 M KCl, 85 mM sucrose, 20 µM EGTA, 20 mM HEPES,    
pH 7.4 
Coupling buffer – 50 mM Na2CO3, pH 9.6 
Developing buffer – 133 mM glycine, 83 mM Na2CO3, pH 10.7 
CTR cocktail - 10 mM ATP, 80 mM CP, 0.5 mg/ml CPK, 0.1 mg/ml biotin-insulin,     
10 mM MgCl2, 40 mM NaCl, 10 mM DDT and 50 mM HEPES, pH 7.5 
Dilution buffer – 0.05% Triton-X 100, 50 mM NaCl, 1 mg/ml heparin, 10 mM Tris,    
pH 7.5 
Incubation solution - av-β-gal PNS, equal protein concentration of bi-Tf  PNS,  
30 µl of  solution X and BB up to 50 µl per well 
Lysis buffer – 10% Triton-X 100, 1% sodium dodecyl sulphate (SDS), 50 µg/ml biotin-
insulin, 10 mM Tris, pH 7.5 
MBG buffer - 0.3 mM MBG, 1.5 mM MgCl2, 0.1 M NaCl, 19 mM 2-mercaptoethanol, 
25 mM Tris, pH 7.5  
Phosphate buffered saline (PBS) – 0.14 M NaCl, 0.01 M sodium phosphate, pH 7.4  
Solution X - 16.7% of CTR cocktail (Figure 11) and 83.3% of BB 
Uptake buffer – 150 mM NaCl, 1 mg/ml glucose, 1 mg/ml bovine serum albumine 
(BSA), 25 mM HEPES, pH 7.4 
Washing buffer (WB) – 1% Triton-X 100, 0,1% SDS, 50 mM NaCl, 1 mM EDTA,       




General laboratory equipment 
Weighing scale Precisa 180A was purchased from Sartorius (Hanover, Germany), 
Varifuge 3.0 RS centrifuge was obtained from Heraeus Instruments (Germany), 
Eppendorf centrifuge 5417R was from Eppendorf (Hamburg, Germany), OptimaTM LE-
80K ultracentrifuge and Beckman type 50.4 Ti ultracentrifuge rotor was from Beckman 
Coulter (USA), Sunrise absorbance reader was from Tecan (Austria) and cell cracker 
(stainless steel ball homogeniser) was from European Molecular Biology Laboratories 
(Heidelberg, Germany). Medium binding strips 6301 (wells) were purchased from 
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Thermo Electron Bioscience (Basingstoke, UK) and second type of wells was from 
Jencons-PLS (Leighton Buzzard, UK). 
 
Cell culture 
Neubauer haemocytometer was obtained from Weber Scintific (Sussex, UK).  
 
Fluorescence measurement 
FLUOstar OPTIMA machine was purchased from BMG LabTechnologies 





Maintenance of cells 
K562 cells were grown in RPMI 1640 medium containing L-glutamine enriched 
with 10% FBS, 100 U/ml penicilin and 100 µl/ml streptomycin. The cells were 
maintained in a CO2 incubator (5% CO2 atmosphere, 37°C). The cells were split in a 
laminar flow cabinet at a cell density of 1 × 106 cells per ml. Usually 8 ml of confluent 
cells were added into 12 ml of pre-warmed medium in a sterile 75 ml flask. Passage 
numbers, total volume and date of splitting were reco ded. The maximum passage 
number used was 50. 
 
Cell number evaluation 
A Neubauer haemocytometer was cleaned with ethanol and firmly covered with a 
coverslip. Cells in a flask were resuspended gently, 20 µl was removed and mixed with 
the same volume of 2% (v/v) trypan blue solution. Approximately 10 µl were placed at 
the edge of a coverslip. The haemocytometer was situated under the microscope and the 
living cells in one quadrant were counted. Trypan blue dye can permeate only a dead 
cell membrane, therefore blue stained cells were not counted in a cell number 
evaluation. The result was determined by the following formula: 
 
cells/ml = number of viable cells per quadrant × dilution factor × 104 
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Bradford protein assay 
Bradford protein assay is a spectroscopic method used for determination of a 
protein concentration of a solution. A protein-depend nt colour change is measured. 
The colour of a Coomassie Brilliand Blue G-250 dye is pH dependent. Under the acidic 
conditions a doubly-protonated red form is most stable. However when binding to a 
protein with certain basic amino acids the unprotona ed blue form becomes the more 
stable one. This method can not be used in the presenc  of detergents. Protein standards 
(most often BSA) are necessary for this assay. The Bradford dye stock, which is stable 
in a dark bottle at 4°C, contains 100 mg of Coomassie Brilliant Blue G-250, 50 ml of 
95% ethanol and 100 ml of 85% H3PO4  made up to 1 l with distilled water. The non-
linear calibration curve was usually measured for 0, 2, 5, 10 and 20 µg of BSA. The 
BSA was dissolved in a distilled water and finally 800 µl of the Bradford dye stock was 
added up to 1000 µl. The measured samples were diluted 1/100 and 1/10 with water and 
5 µl of each was added into separate tubes containing 195 µl of water and 800 µl of dye 
stock. After adding 200 µl of each sample into 96 well plate the absorbance was
measured using 595 nm filter. The protein concentration of the samples was estimated 
by comparison of the absorbance with the calibration curve. 
 
MBG assay  
MBG buffer was prepared and stored in 50 ml tube at – 20°C. It was pre-warmed to 
37°C in a water bath and centrifuged at 1000 rcf for 5 min before each assay. Purchased 
av-β-gal was diluted with sterile PBS to final concentration 1 unit per 1 µl, divided into 
aliquots of 10 µl and stored at – 20°C. The stock of β-galactosidase was prepared 
similarly with the final concentration 5 units per 1 µl. A calibration of increasing 
amount of enzyme in MBG buffer was prepared on ice in 1.5 ml eppendorf tubes and 
incubated for 60 min at 37°C. The total volume of samples was usually 200 µl. 
Developing buffer (1 ml) was added into each sample to block av-β-gal (or β-gal) 
activity. Finally 200 µl of each sample were removed and added into 96 Costar well 
plate. The fluorescence was measured on FLUOstar OPTIMA reader with 360 nm 
excitation and 460 nm emission filter. Gain 1000 or 2000 were used for most of the 
experiments. 
This assay was adapted to fusion assay when the captured av-β-gal complex was 
quantified rather than the free enzyme in a tube. 
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Postnuclear supernatant (PNS) preparation 
Confluent K562 cells (1 million cells/ml) were collected by centrifugation (5 min, 
1000 rcf), washed 3 × with PBS and were resuspended in twice pellet volume of uptake 
buffer containing either av-β gal (0.5 mg/ml) or bi-Tf (1 µM). The cells were left to 
internalize the probe for 1 hour at 16 - 20°C with intermitent mixing. Av-β-gal probe 
had to be dialysed in uptake buffer against buffer A with 10 000 dialysis tube for 2 
hours at 4°C before internalization to remove possible inhibitors of fusion. The 
temperature of internalization step is crucial to let the cells accumulate the probes in 
early endosomes. At 16 – 20°C the probes accumulate in EE and do not traffic to the 
next stages of endocytic pathway or to recycling vesicl s in case of bi-Tf nor towards 
lysosomes in case of av-β-gal. After the internalization the cells were prepared for 
breakage. The cells were washed 5 × with ice cold PBS and resuspended in twice the 
pellet volume of breaking buffer (BB). A stainless steel ball homogeniser (cell cracker) 
was placed on ice with two 5 ml syringes and was used for homogenisation (cell 
breakage). The breakage and all the steps after internalization were performed on ice to 
prevent probes from moving into next compartments of endocytic pathway. About 6 
plunges with 8.004 size ball of cell cracker were made. The breakage was observed 
under the microscope. Trypan blue was used for staining of dead cells. For next 
experiments 90% of cell breakage was required. Postnuclear supernatant (PNS) 
containing endosomes and other membranes was separated f om heavier nuclei and 
intact cells by a centrifugation step (1000 rcf, 5 - 10 min, 4°C). PNS was harvested 
(upper layer) and dialysed  for 2 hours against  ice cold breaking buffer (10 000 dialysis 
tube). The concentration of proteins was determined with Bradford protein assay and 
aliquots of 100 µl were made, snap frozen in liquid nitrogen and stored at -80°C. It has 
been shown that samples retain fusion activity when stored under these conditions. PNS 
containing either av-β-gal or bi-Tf inside early endosomes were prepared in the same 
way. 
 
Cytosol from K562 cells preparation 
The process is very similar to PNS preparation. K562 cells were harvested, washed 
with PBS and put on ice. BB was prepared and pre-cooled. The cells were resuspended 
in twice the pellet volume of BB and let to swell on ice for 5 min. The ball homogeniser 
was set up and placed on ice. The cells were broken as described above and centrifuged 
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for 10 minutes at 1500 rcf. The supernatant was dialysed against ice cold BB for 2 hours 
at 4°C. The sample was loaded into microfuge tubes and centrifuged at 4°C for 5 min at 
90000 rcf. The upper layer was collected, protein co centration was measured and 
aliquots were snap frozen in liquid nitrogen and stored at -80°C. 
 
Preparation of wells 
Anti-transferrin antibody (usually 4 µg per well) was diluted with coupling buffer 
and the solution (350 µl) was added into wells. Binding was performed in parafilm 
covered wells overnight at 4°C. Alternatively, bindi g was performed for 3 hours at 
37°C. The wells were then washed three times with PBS, twice with washing buffer 
(WB) and incubated 15 min at 37°C with WB. One more washing with WB and three 
more with PBS followed. The wells were filled with PBS and stored at room 
temperature until loading with samples. 
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5. RESULTS AND DISCUSSION 
 
5.1. Fluorometric method for measuring β-galactosidase activity (MBG assay) 
 
β-Gal is an enzyme biosynthetised by the bacterium Escherichia coli. For 
maintenance of the active conformation the SH groups in the catalytic site are important 
and their presence makes the enzyme quite succeptible to oxidation. Magnesium and 
sodium are activators, but heavy metals, which complex sulfhydryl groups, and EDTA, 
which chelates magnesium, are inhibitors. This tetrameric protein can hydrolyse natural 
disacharide lactose and many synthetic substances. Fluorogenic substrates, such as 
methylumbelliferyl-β-D-galactopyranoside (MBG, Fig. 3a), are used in various 
detecting systems for the presence of this enzyme. MBG is a highly sensitive substrate 
for determination of glucuronidase levels when the rel ased methylumbelliferone (7-
hydroxy-4methylcoumarin, MU, Fig. 3b) is monitored. MU fluoresces strongly in 
ultraviolet light at pH 9-10, its conjugates show little or no fluorescence (Strachan R. et 
al., 1962). Wavelenghts 360 nm for excitation and 460nm for emission were used. The 
fluorescence is approximately 100 × more intense at pH 10 than at pH 7 and the 
stability of fluorescence is increasing with the pH. The alkalisation of the system with 
developing buffer not only stabilizes MU, but also tops the reaction, because pH 


















Figure 3. (a) Structural formula of MBG, which is non-fluorescent and can be 
converted by β-gal to MU (b), which fluoresces in ultraviolet light at higher pH. 
 
The initial goal of this study was to generate a calibr tion curve for β-gal and av-β-
gal concentration, the latter is used as a signal-making probe in in vitro fusion assay of 
EE. The fluorescence was measured after 1 hour incubation of samples with increasing 
concentration of β-gal in MBG buffer (Fig. 4). The stock of MBG buffer was stored     
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at -20°C and heated to 37°C and centrifuged before us . The graph shows the 
concentration dependent increase of the β-gal activity, the detection limit is 10-5 units.  
 






















Figure 4. Calibration curve of β-gal (MBG assay). Solutions (200 µl) of enzyme in 
MBG buffer were prepared and incubated for 1 hour at 37°C in plastic eppendorfs. The 
reaction was stopped by dilution with developing buffer (1 ml). Final solution (200 µl) 
was added into each well of a Costar 96 well plate and the fluorescence was measured 
(gain 1000).  
 
5.2. Avidin-β-galactosidase characteristics 
 
MBG assay was repeated with increasing amounts of av-β-gal and a calibration 
curve was determined (Fig. 5). The possible change i  the activity of modified enzyme 
and the increase of detection limit were investigated. More concentrated solutions of 
enzyme in MBG buffer were used, because lower activity of modified enzyme was 
assumed.  
Experiments were also performed to investigate the eff cts of time (Fig. 6), 
temperature (Fig. 7) and the amount of substrate. 
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Figure 5. Calibration curve of av-β-gal (MBG assay). The detection limit is 
approximately 10 × higher than the one of β-gal. Error bars represent the mean and the 
standard deviation. 
 
Time dependence with two different concentrations of enzyme in MBG buffer was 


























Figure 6. Solutions containing 0.1 and 0.01 units of av-β-gal in MBG buffer (200 
µl) were prepared and incubated from 10  to 60 min at 37°C. The preparations were 
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made on ice and one sample kept on ice was used as a control (blank) value. All the 
samples were diluted at the same time with 1 ml of developing buffer and fluorescence 
of 200 µl of the final solution was determined.  
 
A similar assay was performed at different temperatures. The optimal temperature 
for most of human-body enzymes is close to 37°C. There is a significant decrease in 


























Figure 7. The samples were prepared the same way as for the calibration curve 
measurement (Fig. 4) and incubated for 60 minutes at different temperatures.  
 
The last experiment testing the av-β-gal activity clarified the amount of substrate 
that can be converted after 1 hour incubation at 37°C. The volume of substrate was 
increased and therefore the concentration of enzyme was decreased. The solution of 
MBG used until now (200 µl of 0.3 mM MBG buffer) contains 60 nmol of substrate. 
This amount was not enough to saturate 0.1 unit of enzyme. When the volume of MBG 
buffer was increased to 300 µl (90 nmol) and 400 µl (120 nmol) the fluorescences of 0.1 
unit of av-β-gal were equal, therefore the conclusion is that te saturation of 0.1 unit of 
av-β-gal lies between 60 and 90 nmol of MBG (data not sh wn). 
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5.3. Determination of anti-transferrin antibody specifity 
 
Bi-Tf (a receptor-bound marker) is used as a compleentary probe to av-β gal in 
the fusion assay. Avidin has an exceptionally high affinity to biotin. Dissociation 
constant of avidin-biotin complex is 10-15, which is extremely high  and higher than    
10-11 for antibodies-antigens or 10-5 for enzyme-substrate complex (Bayer A. E. et al, 
1990). When these markers are separately introduced into EE, that are afterwards 
allowed to fuse, the probes are expected to associate and form β-gal-av-bi-Tf complex. 
The efficiency of fusion can be measured through β-gal, which can convert non-
fluorescent MBG to a fluorescent product (MBG assay). Before fluorimetry the 
complex has to be released from EE and specifically captured in the well coated with 
anti-transferrin antibody. The specifity of anti-Tf antibody had to be therefore verified 
before fusion assay could be performed. 
The wells were prepared as described in Materials and Methods and an increasing 
amount of anti-Tf antibody was placed in the indiviual wells. The solution containing 
av-β-gal (2.63 nM), bi-Tf (2.63 nM) and cytosol (2 - 4 mg of proteins per ml) was 
prepared. The amount of av-β-gal used for this experiment was chosen to correspond 
with 0.1 unit of enzyme. A control solution with av-β-gal and cytosol only for a 
measurement of non-specific binding of avidin to the surface of the wells was also 
prepared. Cytosol provided proteins for possible competition with exogenous transferrin  
for the anti-transferrin antibody. Water rather than breaking buffer (BB) was used as a 
solvent to dilute the samples up to 50 µl per well before incubation. After 30 minutes of 
incubation at 37°C the probes were expected to be ttally bound to form  β-gal-av-bi-Tf 
complexes. Non-complete lysis buffer (no biotin-insulin inside, 10 µl per well) and 
dilution buffer (300 µl per well) were added. The samples were centrifuged at 10000 rcf 
for 10 min at 4°C and pre-prepared wells containing PBS were re-filled with 350 µl of 
centrifuged sample. The samples were incubated for 3 hours and then the wells were 
washed as described. Substrate (350 µl of MBG buffer) was added to each well and 
these were incubated for 1.5 hour at 37°C. As already described MBG provides a 
substrate for av-β-gal, which is bound to bi-Tf-anti-Tf antibody-well, and a fluorescent 
product is released. The fluorimetry (300 µl of final solution) was read after diluting 
300 µl of content of each well with 1 ml of developing buffer (Fig. 8). In this 
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experiment lysis buffer and dilution buffer were used to simulate the conditions of 
fusion assay. 
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Figure 8. The sample (350 µl) was placed in each well. In the control samples 
biotin-transferrin was omitted for measuring non-specific binding of av-β-gal to anti-Tf 
antibody. There was a clear difference between complete (β-gal-av-bi-Tf) and control 
(av-β-gal only) sample. As the av-β-gal is not bound to anti-transferrin antibody, it does 
not bind to the well, and therefore the fluorescence is close to the blank value. 
 
Another experiment was carried out to assess the specificity of the av-β-gal activity 
on anti-Tf antibody coated wells. An excess of biotin-transferrin was added into 
individual samples to investigate whether this would compete with the β-gal-av-bi-Tf 
complex for the antibody. Up to 500 times excess of bi-Tf was used. The symbol R is 
used to express the relationship between the amounts f markers inside the well. 
 
R = [bi-Tf]/[av-β-gal] 
 
This single probe was supposed to compete with β-gal-av-bi-Tf complex for anti-Tf 
antibody bound to the well surface and it was predict  that this would decrease the 
activity (Fig. 9).  
 37 






















Figure 9. Different volumes of bi-Tf were added into individual samples before 30 
min incubation at 37°C. The X axis values shows the amount of [bi-Tf]/[av-β-gal] in 
each well. The results confirm the theory of decreasing signal with increasing amount of 
bi-Tf. 
 
5.4. Localisation of probes in postnuclear supernatnt 
 
The procedure for PNS preparation is described in Materials and Methods. The aim 
of this experiment was to prove that av-β-gal is localised inside of EE within the PNS 
fraction, the probe was quantified with MBG assay. PNS containing biotin-transferrin 
inside endosomes served as a control. MBG assay was performed on particular fractions 
after the PNS was centrifuged at 25000 rcf and 4°C for 10 minutes. The upper fraction 
(cytosol) was isolated and the pellet (membranes including endosomes) was 
resuspended in BB and centrifuged again to remove any residual cytosol. The pellet was 
finally resuspended in BB up to the same volume as the cytosolic fraction. This fraction 
was called membranes and  the protein concentration of all the samples was measured. 
β-Galactosidase activities in the cytosol, membranes and intact PNS was then 
performed using the MBG assay. Prior to this, non-cmplete lysis buffer (10 µl, lacking 
biotin-insulin) was added into each sample and mixed g ntly. This will lyse the 
endosomes and the enclosed probes will be released. The samples were diluted to 
certain protein concentration with necessary volume of BB up to 50 µl. MBG buffer 
(300 µl) was added and the samples were incubated for 1 hour at  37°C. Developing 
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buffer (1 ml) alkalised the samples and inactivated av-β-gal. Finally the fluorescence 
was measured (Fig. 10). The experiment was carried out in 1.5 ml eppendorfs. 
 



































Figure 10. The numbers in brackets represent the protein concentration of samples. 
The fractions designated as Membr. represent fractions enriched in early endosomes. 
The graph shows that marker is mostly localised inside this fraction. The possibility 
exists that the fluorescence limit lies at 14000, thus the real values may be much higher. 
The same experiment was repeated with lower protein concentration (0.2 mg/ml and 0.5 
mg/ml) to address this issue and the difference betwe n membrane fraction and cytosol 
was 13000 fluorescence units (data not shown) with the membrane fractions having  
higher fluorescence than PNS fractions. 
 
This experiment required adjustment of protein concentration of individual 
fractions to the same value. Adding different volumes of samples and BB could have 
been a source of some inaccuracy. Also measuring the protein concentration was 
dependent on the quality of pellet dissolving. 
 
5.5. Fusion assay 
 
These preliminary experiments then allowed for investigation of the full fusion 
assay. Two types of EE containing complementary probes (two types of PNS) were 
incubated for 30 - 60 min at 37°C in the presence of energy, biotin-insulin for 
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scavanging av-β-gal outside the endosomes, Na+, Mg2+ and the reducing agent DDT. 
EE are assumed to fuse and fusion allows the probes t  combine and form β-gal-av-bi-
Tf complex. When the membranes are lysed with deterg nt, the complex is released and 
can be captured in the wells coated with anti-transferrin antibody. Finally the complex 
can be detected by MBG assay. 














Table 2. The stocks of fusion assay reagents. 
 
Preparation of wells 
This step is described in  Material and Methods. 
 
In vitro fusion of early endosomes 
Incubation solutions (50 µl per well) were prepared and were composed of PNS 
with endocytosed av-β gal, equal protein concentration of PNS with endocyt sed bi-Tf, 
30 µl of solution X (described in Materials and Methods) and BB to give a final volume 
of 50 µl per well. The amount of both postnuclear supernata ts is determined by final 
protein concentration of incubation solution, which optimately should be between 2 - 4 
mg/ml (Wessling-Resnick M. et al., January 1990). When the protein concentration is 
lower than this, there may be an insufficient amount of proteins required to support 




ATP 0.1 M 
pH 7.0 (247 mM NaOH) 
stored at -80°C 
CP 0.8 M stored at -80°C 
CPK 10 mg/ml 
in 10 mM Tris, pH 7.5, 0.1% BSA 
stored at -80°C 
Biotin-Insulin 1 mg/ml 
in 10 mM Tris, pH 7.5 
stored at -20°C 
DDT 1 M  
MgCl2 0.1 M  
NaCl 4 M  
HEPES sodium salt 0.5 M pH 7.4 
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inhibitory factors. Solution X is composed of 16.7% of CTR cocktail (Fig. 11) and 
83.3% of BB. Non-complete CTR cocktail without ATP, CP and CPK can be prepared 
as a stock, that is stored at -20°C. ATP and energy re enerating system completes the 
CTR cocktail when the fusion assay is carried out. All the preparations must be 
performed on ice. The final concentrations of reagents in incubation buffer correspond 
to conditions used by Braell (Wessling-Resnick M. et al., January 1990): 1 mM ATP, 8 
mM CP, 50 µg/ml CPK, 10 µg/ml biotin-insulin,  1 mM MgCl2, 4 mM NaCl, 1 mM 
DDT and 5 mM HEPES. Samples containing no av-β-gal PNS and samples containing 
no bi-Tf  PNS were used as controls. The samples were incubated for 30 min at 37°C  in 
plastic eppendorf tubes, a sample containing both marked types of endosomes incubated 
on ice was utilised as a control. No fusion should occur at this temperature.  Fusion was 
terminated by addition of lysis buffer (10 µl per well). That contains strong detergents 
destroying biological membranes. The samples were vo texed gently and 300 µl of 
dilution buffer was added per well. Samples were vortexed again and centrifuged at 4°C 






















Figure 11. CTR cocktail. For the preparation the stocks of reagents described in 
Table 2 were used.  
 
Binding to the wells 
After the centrifugation step the samples (350 µl per well) were carefully added 
into pre-prepared wells and incubated at 37°C for 3 hours. Subsequently the wells were 
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washed to remove all the non-bound substances. The proc ss of subsequent washing has 




The wells were filled with 350 µl of MBG buffer and incubated for 90 - 120 min at 
37°C. Finally 300 µl was carefully removed from each well (it was important to avoid 
touching the well surface) and mixed in sterile plastic 1.5 ml eppendorf with 1 ml of 
developing buffer. 300 µl of this solution was removed into a well of a Costar 96 well 
plate and the fluorescence of the sample was determin d (Fig. 12). 
 






















Figure 12. First attempt at the fusion assay. The protein concentration of 
incubation solution was 3.6 mg/ml and gain 2000 was used for fluorescence 
measurement.  
 
Unexpectedly, the signal from tubes kept at 4°C washigher than those kept at     
37°C. However no signal was detected in wells incubated in the absence of antibody. 
The fluorescence of sample without PNS containing bi-Tf was expected to be lower and 
this was confirmed in this experiment. 
The experiment was repeated in a cold room, where the temperature did not exceed 
4°C (Fig. 13). The results from this experiment show the expected higher values at     
37°C, but the fluorescence values were almost 10 × higher in comparison with the 
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previous experiment. This was surprising as the same samples were used for both 
experiments. When these experiments were repeated we were unable to observe a 
temperature dependent fusion as shown in Figure 13. 
 























Figure 13. Fusion assay performed in the cold room. The difference between 37°C 
fusion sample and a 4°C control sample was about 3000 fluorescence units for gain 
2000. Conversely there was much higher background arising from the fluorescence 
values of the sample incubated in uncoated wells.  
 
Modifications of fusion assay 
In view of the fact that we could not reprodicibly observe temperature dependent 
fusion a number of different variations on this method were attempted. These included 
using wells from an alternative manufacturer, altertions in composition of CTR 
cocktail, different method of PNS preparation or addition of  extra cytosol to the fusion 
mixture. However we were unable to reproducibly obtain temperature / energy 
dependent fusion. 
One mole of avidin binds to 4 moles of biotin, 1 mole f transferrin binds 4 moles 
of biotin and 1 mole of β-gal binds 1 mole of avidin. The probes combine at a ratio 1:1 
and this is why equal protein concentrations of both types of PNS were used. But 1 
mole of  β-gal can bind up to 4 moles of avidin and therefore different combinations of 
mixed PNS were attempted. But again we did not observe any temperature dependent 
fusion. 
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The composition of reagents in the CTR cocktail was also assessed. The ATP 
preparation used contained magnesium and a possibility exists that the Mg2+ 
concentration was in excess. Fusion assays were ther for  performed without the 
addition of MgCl2 (Fig. 14). However the results show that this did not improve the 
assay. 
 






















Figure 14. The assay was performed with CTR cocktail lacking extra added Mg2+, 
which was assumed to inhibit fusion. Protein concentration of samples was 2.2 mg/ml. 
  
The PNS used in these experiments was prepared with the stainless steel ball 
homogeniser (cell cracker). There may be a possibility that this method could be too 
aggressive and organelles like endosomes and lysosomes could be broken thus releasing 
the internalized probes. Released lysosomal enzymes could degrade the markers and 
inhibit fusion. There is an alternative method for PNS preparation. A freez-thaw method 
with violent mixing was then attempted (Fig. 15). The cells with endocytosed marker 
were resuspended in two pellet volumes of BB and snap frozen in liquid nitrogen. The 
samples were gently thawed and then vortexed vigorously. The process was repeated 
three times. PNS was divided from intact cells and nuclei by centrifugation. However 
the PNS from these experiments did not support fusion. Moreover the integrity of 
lysosomes, unlike endosomes, is not maintained during freezing and thawing 
(Wessling-Resnick M. et al., January 1990). Another possible method for PNS 
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preparation is passing the cells through a narrow gauge needle, but this method was not 
investigated. 
 



















Figure 15. Fusion assay performed with PNS prepared by freezing-thawing with 
violent mixing. The signal of sample incubated at 37°C did not differ from the sample 
incubated on ice. 
 
Finally experiments were performed to investigate whether supplementing fusion 
assays with prepared cytosol could enhance the low fusion signal. Various amounts of 
cytosol giving concentration of 0.5; 1.0 and 2.0 mg/ l were investigated and the results 
are shown in Fig. 16. The signal at 37°C was not enhanced in any of these cytosol 
supplemented assays. It is likely that cytosol did not have a positive effect on fusion, 
because there might have been enough factors important for fusion of EE. It seems like 
the fusion was detected, because samples incubated on ice gave lower values of 
fluorescence than samples incubated at 37°C. Once again the data shown in Figure 16 
was not consistently observed and in subsequent assays the 4°C control values were 































































































Figure 16. The effect of supplementing the fusion assay with cytosol was assessed. 
The numbers in brackets represent protein concentration of cytosol in the incubation 
solution. Four sets of samples were prepared: 0 mg/ml, 0.5 mg/ml, 1 mg/ml and 2 
mg/ml additional protein concentration. First three colums serve as a standard where no 
cytosol was added. The total protein concentration of samples was 2.9; 3.4; 3.9 and 4.9. 
Gain 2000.  
 
There was a concern that the probes were outside the ndosomes where they could 
even in the presence of insulin-biotin combine and lead to false results. A simple 
modification was attempted whereby the endosomes containing internalized probes 
were isolated from the PNS via centrifugation at 25000 rcf for 10 min at 4°C. The 
resulting pellet was washed with BB, centrifuged again and resuspended in BB. This 
‘purified’ PNS and extra cytosol were added into incubation buffer and fusion assay 
was performed. There was no improvement in fusion compared with previous assays. 
 
Despite the fact that the MBG assays was developed and specific binding of the β-
gal-av-bi-Tf to the transferrin antibody in the wells was shown, we were unable to 
reprodicibly observe fusion at 37°C.  Thus we were unable to determine the effects of 
CPP on early endosome fusion. 
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5.6. Assay for measuring lysosomal degradation of avidin-β-galactosidase 
 
One possibility for the the low efficiency of fusion was degradation of the av-β-gal 
in the lysosomes of the cells. We therefore determined whether we could measure the 
degradation of this probe under similar conditions to those used for the fusion assays. 
The degradation assay is based on a published method (Nieland J. F. T. et al, 
2004). Confluent K562 cells were collected and washed 3 × with PBS. Cells were 
resuspended in twice the pellet volume of ice-cold uptake buffer containing 0.5 mg/ml 
av-β-gal and incubated with intermitent mixing for 1 hour at 19.5°C. A sample without 
enzyme was prepared for a control. The samples wereashed 5 × with ice cold PBS to 
remove any non-internalized marker and were resuspended in uptake buffer without 
BSA and av-β-gal. Aliquots for chasing at 37°C and control on ice were then prepared. 
During this 37°C incubation, the marker was expected to follow the endocytic pathway 
from EE through endosomal carrier vesicles to LE and lysosomes. LE and mainly 
lysosomes contain degradation enzymes which will cleave and degrade av-β-gal and 
therefore the fluorescence which is measured afterwards is expected to decrease with 
the time of incubation. After the chase, the cells were resuspended in twice the pellet 
volume of ice-cold BB and were broken. Freezing-thawing method previously described 
for cell breakage was used. The samples were centrifuged for 5 min at 1000 rcf at 4°C 
and PNS was collected. The protein concentration of all the samples was measured and 
MBG assay was performed. PNS was mixed with lysis buffer (10 µl) to release av-β-gal 
from organelles and BB was added up to 50 µl. The protein concentration of this 
solution was adjusted to 1 mg/ml. MBG buffer (300 µl) was added and the samples 
were incubated for 1 hour at 37°C. The reaction wasstopped with developing buffer    
























Figure 17. In control sample no enzyme was endocytosed. Chasing on ice did not 
allow the probe to move from EE and no degradation was detected. 
 
 As expected the maximal fluorescence was observed in samples incubated on ice 
after the initial pulse. However we were surprised to observe that even 10 min of chase 
resulted in a significant reduction in cell associated av-β-gal activity. This rapid 






This diploma thesis was carried out under the sponsorship of Erasmus program. 
The aim of this study was to set up an in vitro assay of early endosome fusion at the 
Welsh School of Pharmacy. The method was originally described by Braell and 
Wessling-Resnick using internalized probes in K562 cells (Wessling-Resnick M. et al., 
January 1990). Two complementary probes (avidin-β-galactosidase and biotin-
transferrin) were separately introduced into early endosomes. Once the PNS was 
prepared conditions suitable for fusion were applied and the resulting complex was 
determined using fluorimetry. Initially it was necessary to develop a β-gal activity assay 
in the laboratory, and determine the specificity of c mplex binding to the transferrin 
antibody on the wells. These aims were successfully completed and this then allowed 
progress to development of the full fusion assay. Unfortunately despite numerous 
attempts utilising a number of different conditions, fusion could not be reproducibly 
measured.  Time-constraints hindered further experiments that may have yielded more 
promising data.  
Once this assay will be set up it can be used to answer many questions under the 
remit of drug delivery on the endocytic pathway. One of these as previously noted 
involves the effects of cell penetrating peptides on endosome integrity and fusion.  
The experiment for measuring activity of endocytic probe during passage through 
endocytic pathway in vitro was performed and temperature-dependent degradation  was 
observed. The signal of the probe decreased with the time of incubation at 37°C 
suggesting the probe was degraded by lysosomal enzymes. The results obtained show 
that there is a significant and rapid reduction in β-gal activity with chasing at 37°C. This 
needs to be further investigated for example by performing the same experiments at 





Tato diplomová práce byla zpracována pod záštitou programu SOCRATES/ 
ERASMUS na Welsh School of Pharmacy v Cardiffu. 
Cílem mé práce bylo modifikovat již vyvinutou metodu (Wessling-Resnick M. et 
al., January 1990) a přizpůsobit ji podmínkám tamní laboratoře. Předmětem studia byla 
subpopulace tzv. časných endosomů, které vznikají těsně při povrchu plasmatické 
membrány po rozpadu klatrinového pláště. Jednou z jejich vlastností je schopnost 
spojovat se, fúzovat, čímž vzniká nadbytečná membrána potřebná pro další osud těchto 
organel. 
Ve svých experimentech jsem pracovala se dvěma komplementárními markery. 
Jedním z nich byl avidin navázaný na enzym β-galaktosidasu, která štěpí kromě laktosy 
také syntetické substráty za vzniku příslušných  produktů. V této studii byl produktem 
specifické hydrolýzy methylumbeliferylgalaktosidu intenzivně fluoreskující 
methylumbeliferon. Druhým markerem byl biotinylovaný transferin. Podstatou 
komplementarity markerů je vysoká afinita avidinu k biotinu. Dvě skupiny buněk byly 
inkubovány se zmíněnými markery a po jejich akumulaci v  endosomech následovala 
mechanická destrukce buněk za uvolnění organel. Oba typy endosomů byly smíchány 
v prostředí podporujícím jejich fúzi. Spojením dvou endosomů nesoucích různé 
markery došlo k jejich rychlé kombinaci za vzniku komplexu β-galaktosidasa – avidin – 
biotin – transferin. Přidáním detergentu se rozpadla membrána spojené organely  
uvolnil se její obsah. Ke kvantifikaci komplexu byl použit ELISA test. Celý komplex 
byl prostřednictvím transferinu zachycen na povrchu jamky s navázanou protilátkou 
proti transferinu a po přidání substrátu pro β-galaktosidasu byla změřena fluorescence 
vzorku.  
Ačkoli přípravné experimenty poskytovaly optimistické výsledky, samotná fúze 
neprobíhala reprodukovatelně jako proces závislý na teplotě a energii. Z časových 
důvodů se mi nepodařilo přizpůsobit podmínky pro optimální průběh metody. 
V současné době na ní pracuje zbytek týmu. Po úspěšném zavedení metody fúze 
časných endosomů in vitro budou vytvořeny podmínky pro testování nejrůznějších 
léčiv, i těch potenciálních, a jejich vlivu na tento krok endocyt sy. Cílem je najít 
selektivní inhibitory fúze s potenciálem rozštěpi  endosomální membránu. Tím by byla 
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otevřena cesta široké škále léčiv, která jsou za normálních okolností zachycena v 
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